It's a strange one but there's a rather large story brewing that this person is the US president.
Briscoe
prieš 2 savaites
GLP-1s are having measurable effects on US obesity
FXfunded
prieš 4 savaites
NEW ATH
new ATH for LLY as they continue to dominate the healthcare sector. me personally my PT for this company is 1500 dollars, hopefully upwards from here!
FXfunded
praėjusį mėnesį
LLY drug trial
BulldogInvesting
praėjusį mėnesį
FFS
NoRiskNoFun
prieš 2 mėnesius
Lily getting a shout out from mrT on Truth
NoRiskNoFun
prieš 2 mėnesius
Eli Lilly Q1 2026 earnings 📊
FXfunded
prieš 2 mėnesius
Earnings
Earnings tommorow, I just bought my first position into this company , what’s peoples thoughts , I didn’t enter a huge position so I’ll add more id we drop after earnings.
Briscoe
prieš 2 mėnesius
Foundoyo gets 1,400 prescriptions in the first week
My little Lilly pad 🐸 is the only thing keeping me afloat today!
NetWorthNinja
prieš 5 mėnesius
Eli Lilly Takes the Lead in Growth 2026 🚀💊
Eli Lilly delivered an excellent earnings report today 📈💊. Revenue grew 43% to $19.3B, and the company raised its 2026 guidance to a massive $80B–$83B, beating analyst expectations by roughly $5B 💥. This strength highlights a clear divergence from Novo Nordisk, which warned of pricing pressures and a potential 2026 slowdown ⚠️.
As a result, Eli Lilly is being moved to the top holding (24%) in my Growth 2026 pie 🧠📊. This decision is driven by strong 2026 earnings visibility, superior execution in the GLP-1 market, and clear operational momentum 🚀.
That said, after today’s 7%+ jump, I’m taking a patient approach before adding more ⏳📉. While Lilly carries the highest conviction in the pie, waiting for a more attractive entry keeps the strategy disciplined 🎯 especially while tech names like Datadog and CrowdStrike offer compelling buy-the-dip opportunities at lower valuations 💻🛡️📉.
Sid89
prieš 5 mėnesius
$LLY Earnings: Q4 2025
NoRiskNoFun
prieš 5 mėnesius
Eli Lilly Q4'25 earnings 📊
NoRiskNoFun
prieš 5 mėnesius
Eli Lilly earnings released 📊
NetWorthNinja
prieš 5 mėnesius
Headline: All Eyes on Lilly 💊💉 | Novo’s Pain or Lilly’s Gain?
Šiame puslapyje gali būti bendruomenės sukurto turinio, už kurį „Trading 212“ neatsako. Visada atlik savo tyrimą. „Trading 212“ teikia tik vykdymo paslaugą, bet neteikia investavimo konsultacijų ar portfelio valdymo paslaugų.
Turto kaupimas – įprotis. Automatizuokite jį naudodami Pies.
Investuok į paruoštus arba susikurk savo investicijų rinkinius, pasirinkdamas iš daugybės vertybinių popierių ir ETF
Sužinok daugiau
Sužinok daugiau
Žiūrėti vaizdo įrašą
Turėk net brangiausių akcijų, tokių kaip „Google“, „Amazon“ ir „Apple“
Žiūrėti vaizdo įrašą
„Euronext“ Paryžius
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londono vertybinių popierių birža
„Euronext Lisbon“
„Euronext“ Paryžius
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londono vertybinių popierių birža
„Euronext Lisbon“
Peržiūrėk visas prekybos priemones
Pagalba visą parą
29 sekundžių vidutinis atsako laikas
Pradėk kaupti turtą jau dabar
Prisijunk prie daugiau nei 5 mln. naudotojų
Atsisiųsti programėlę
Atidaryti sąskaitą
Atsisiųsk mobiliąją programėlę
Visi pateikti statistiniai duomenys yra globalūs. Klientų skaičius atspindi finansuotas sąskaitas.
Puiku
Įvertinta 4,6/5, remiantis 95 783 atsiliepimais apie
Trustpilot
Įvertinta 4,6/5, remiantis 95 783 atsiliepimais apie
Trustpilot
Pakviestas
Simple and easy to use
Simple and easy to use. Nice to see the daily interest added on as well.
Pakviestas
Best platform for ISAs of all kinds
I have both stock and share and cash ISA with T212. The platform is a breeze to use, transactions within the accounts and between internal and external accounts are a breeze.
Pakviestas
Very good app
Very good app. Easy to see the status of my savings and interest. Feel like they’re responsible well run company
Pakviestas
Great starting interest rate making this a fantastic way to save coupled with an intuitive and easy to use app interface making saving easy to understand
Great starting interest rate making this a fantastic way to save
Pakviestas
Great from start to finish
My account was set up and the funds transferred seamlessly.
Pakviestas
They offer a slick service although I…
They offer a slick service although I could have done with some instructions on how to navigate their app but maybe that’s just me.
Pakviestas
Easy to track my cash ISA
Easy to track my cash ISA - daily updates on interest.
Great intro deal on ISA interest.
Pakviestas
Competitive interest rates easy to…
Competitive interest rates easy to access website and pay out efficient and quick.
All in all convenient company to deal with.
Very satisfied.
Pakviestas
The Cash ISA is easy to use
The Cash ISA is easy to use, simple to add and withdraw funds any time and I haven't had any issues since opening the account.
Pakviestas
Just love it
Just love it, have done from day one !
Wish I had this forty years ago, might be a millionaire by now,😂😂
Pakviestas
Very prompt and helpful advice from…
Very prompt and helpful advice from online staff with any issues.
Pakviestas
Great user experience
Great interface, love the detail shown about where you money is invested and very easy to add funds or move funds
Pakviestas
Prudence facilitation. Thanks
Great app. Encouraging money management and genral financial wisdom and knowledge. Thanks
Pakviestas
Be smart with money
Great interest rates, reliable access which is amazing
Pakviestas
Easy to deposit
Easy to deposit, acct updates quickly, monthly interest, easy access
Pakviestas
Convenient and responsive App and great…
Convenient and responsive App and great interest ratea
Pakviestas
Very easy to track what is happening…
Very easy to track what is happening with your investment. Website easy to negotiate on initial set up and the app has all the info you need.
Interest rate good for 1st year, I’ll see what is available after that.
Pakviestas
Really easy and simple to use and quick…
Really easy and simple to use and quick transfers when needed
Pakviestas
Seamless performance and user-friendly…
Seamless performance and user-friendly interface. Would definitely recommend to those who are planning to start their investing journey.
Pakviestas
Simple & Easy
I find the app very easy to use.
Very simple. Would reccomend this way of saving to others.
Pateikiami keli teigiami mūsų klientų atsiliepimai
Mūsų apdovanojimai
Dažniausiai užduodami klausimai
Kokia yra Eli Lilly & Co (LLY) akcijos kaina?
Dabartinė Eli Lilly & Co (LLY) kaina yra 1 117,26 $.
Koks yra LLY52 savaičių maksimumas?
52 savaičių maksimumas LLY yra 1 182,76 $.
Koks yra LLY 52 savaičių žemiausias lygis?
52 savaičių žemiausias LLY kursas yra 623,75 $.
Koks yra LLY savaitės rezultatas?
Per pastarąją savaitę LLY kaina pasikeitė 0,47 %.
Koks yra LLY mėnesio našumas?
Per pastarąjį mėnesį LLY kaina pasikeitė 4,91 %.
Koks yra LLY 3 mėnesių rezultatas?
Per pastaruosius tris mėnesius LLY kaina pasikeitė 22,7 %.
Koks yra LLY 6 mėnesių rezultatas?
Per pastaruosius šešis mėnesius LLY kaina pasikeitė 4,26 %.
Koks yra LLYmetinis našumas?
Per pastaruosius metus LLY kaina pasikeitė 44,98 %.